163 related articles for article (PubMed ID: 27040133)
1. Variable levels of apoptotic signal-associated cytokines in the disease course of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Yang Y; Li F; Du J; Shen Y; Lin J; Zhu X; Luo X; Liang J; Xu J
Australas J Dermatol; 2017 Aug; 58(3):e61-e67. PubMed ID: 27040133
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of case-control studies of cytokines in blister fluid and skin tissue of patients with Stevens Johnson syndrome and toxic epidermal necrolysis.
Stewart TJ; Farrell J; Frew JW
Australas J Dermatol; 2024 Jun; ():. PubMed ID: 38831709
[TBL] [Abstract][Full Text] [Related]
3. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI; Yang JY; Su SC; Huang SP; Wei CY; Chin SW; Chiou CC; Chu SC; Ho HC; Yang CH; Lu CF; Wu JY; Liao YD; Chen YT
Nat Med; 2008 Dec; 14(12):1343-50. PubMed ID: 19029983
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the potential role of cytokines in toxic epidermal necrolysis.
Nassif A; Moslehi H; Le Gouvello S; Bagot M; Lyonnet L; Michel L; Boumsell L; Bensussan A; Roujeau JC
J Invest Dermatol; 2004 Nov; 123(5):850-5. PubMed ID: 15482470
[TBL] [Abstract][Full Text] [Related]
5. Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Carr DF; Wang CW; Bellón T; Ressel L; Nwikue G; Shrivastava V; Bergfeld W; Jorgensen AL; Chung WH; Pirmohamed M
Br J Dermatol; 2019 Jul; 181(1):166-174. PubMed ID: 30613954
[TBL] [Abstract][Full Text] [Related]
6. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment.
Murata J; Abe R; Shimizu H
J Allergy Clin Immunol; 2008 Nov; 122(5):992-1000. PubMed ID: 18692887
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Su SC; Mockenhaupt M; Wolkenstein P; Dunant A; Le Gouvello S; Chen CB; Chosidow O; Valeyrie-Allanore L; Bellon T; Sekula P; Wang CW; Schumacher M; Kardaun SH; Hung SI; Roujeau JC; Chung WH
J Invest Dermatol; 2017 May; 137(5):1065-1073. PubMed ID: 28011147
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing between erythema multiforme major and Stevens-Johnson syndrome/toxic epidermal necrolysis immunopathologically.
Iwai S; Sueki H; Watanabe H; Sasaki Y; Suzuki T; Iijima M
J Dermatol; 2012 Sep; 39(9):781-6. PubMed ID: 22458564
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
[TBL] [Abstract][Full Text] [Related]
10. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
[TBL] [Abstract][Full Text] [Related]
11. The Role of IL-13, IL-15 and Granulysin in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Sadek M; Iqbal O; Siddiqui F; Till S; Mazariegos M; Campbell E; Mudaliar K; Speiser J; Bontekoe E; Kouta A; Farooqui A; Daravath B; Qneibi D; Sadek R; Hoppensteadt D; Fareed J; Bouchard C
Clin Appl Thromb Hemost; 2021; 27():1076029620950831. PubMed ID: 33560872
[TBL] [Abstract][Full Text] [Related]
12. Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis.
Correia O; Delgado L; Barbosa IL; Campilho F; Fleming-Torrinha J
J Am Acad Dermatol; 2002 Jul; 47(1):58-62. PubMed ID: 12077582
[TBL] [Abstract][Full Text] [Related]
13. Diverse expression of TNF-α and CCL27 in serum and blister of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Wang F; Ye Y; Luo ZY; Gao Q; Luo DQ; Zhang X
Clin Transl Allergy; 2018; 8():12. PubMed ID: 29713456
[TBL] [Abstract][Full Text] [Related]
14. Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis.
de Araujo E; Dessirier V; Laprée G; Valeyrie-Allanore L; Ortonne N; Stathopoulos EN; Bagot M; Bensussan A; Mockenhaupt M; Roujeau JC; Tsapis A
Exp Dermatol; 2011 Feb; 20(2):107-12. PubMed ID: 21255088
[TBL] [Abstract][Full Text] [Related]
15. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
16. Recovered patients with Stevens-Johson syndrome and toxic epidermal necrolysis maintain long-lived IFN-γ and sFasL memory response.
Fu M; Gao Y; Pan Y; Li W; Liao W; Wang G; Li C; Li C; Gao T; Liu Y
PLoS One; 2012; 7(9):e45516. PubMed ID: 23029066
[TBL] [Abstract][Full Text] [Related]
17. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
[TBL] [Abstract][Full Text] [Related]
18. Blister fluid composition in a pediatric patient with toxic epidermal necrolysis.
Gandhi M; Kowal-Vern A; An G; Hanumadass M
J Burn Care Res; 2008; 29(4):671-5. PubMed ID: 18535474
[TBL] [Abstract][Full Text] [Related]
19. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders.
Chen CB; Kuo KL; Wang CW; Lu CW; Chung-Yee Hui R; Lu KL; Chang WC; Chen WT; Yun F; Teng YC; Lee HE; Lin JY; Ho HC; Chi MH; Yu-Wei Lin Y; Chang CJ; Lin Y; Ku CL; Hung SI; Chang YC; Chung WH;
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1327-1337.e3. PubMed ID: 33039642
[TBL] [Abstract][Full Text] [Related]
20. In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.
Porebski G; Pecaric-Petkovic T; Groux-Keller M; Bosak M; Kawabata TT; Pichler WJ
Clin Exp Allergy; 2013 Sep; 43(9):1027-37. PubMed ID: 23957338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
